Institute of Cybernetic Surgery Cyberknife
Institute of Cybernetic Surgery Cyberknife
Poland, Wieliszew
Lung cancer treatment cost in Poland is significantly more affordable than in Western Europe, with a diagnostic PET-CT scan ranging from $800 to $1,200. Primary surgical interventions like a lobectomy run from $20,000 to $30,000, while a pneumonectomy costs $20,000 to $35,000. Total expenses depend on the cancer stage, chosen technology, and facility tier. Patients typically achieve 40-60% savings compared to the US. Most advanced oncology centers are located in Warsaw, Otwock, and Wieliszew.
Typical Lung Cancer Treatment Costs in Poland
Bookimed Expert Insight: Advanced localized tumors are best treated at specialized radiosurgery centers. The Institute of Cybernetic Surgery Cyberknife in Wieliszew is a unique Polish center utilizing European Regional Development Funds for innovative care. Patients requiring multidisciplinary support should consider European Health Center Otwock. As Poland's first private hospital for oncology and cardiology, it provides specialized cardio-oncology care essential for older patients or those with heart comorbidities.
| Poland | Turkey | Austria | |
| Tomotherapy | from $15,000 | from $12,000 | from $30,000 |
| Stereotaxic radiosurgery | from $18,000 | from $4,500 | from $17,000 |
| Proton-beam therapy | from $85,000 | from $70,000 | from $80,000 |
| Pneumonectomy | from $20,000 | from $10,872 | from $50,000 |
| Lung cancer surgery | from $18,000 | from $17,000 | from $42,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lung cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lung cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lung cancer treatment journey.
Written by Mariia Mytrofankina
Eligibility for lung cancer clinical trials in Poland depends on your specific tumor mutations and health status. Patients often undergo genetic screening for markers like EGFR, ALK, or ROS1. You can find open studies by filtering for Poland on the ClinicalTrials.gov registry or the EU Clinical Trials Register.
Bookimed Expert Insight: While many search for trials at large public institutes, private centers like European Health Center Otwock offer unique interdisciplinary care. This is vital for patients with heart conditions. Data shows Poland is a top 10 global destination for medical requests. This high volume helps maintain specialized diagnostic infrastructure like PET/CT and robotic systems.
Patient Consensus: Patients note that getting a full genomic panel quickly is essential for matching with targeted therapy trials. Some mention looking at neighboring countries like Germany if local options for specific immunotherapy combinations are limited.
International patients can access targeted therapies and immunotherapy in Polish private clinics. These facilities use oncology drugs approved by the European Medicines Agency (EMA). Access is streamlined through private hubs that skip public waitlists. Patients typically require genetic screening and biomarker testing to qualify for these precision treatments.
Bookimed Expert Insight: Poland serves over 3,000 international patients annually, ranking 7th globally in medical travel. For lung cancer, seeking clinics with dedicated cardio-oncology departments is vital. This specialised focus helps manage the heart-related side effects often caused by specific modern immunotherapies.
Patient Consensus: Patients note that bringing NGS genetic profiling from home speeds up treatment. They suggest confirming drug stock levels and infusion schedules in writing before travelling to Poland.